Carnival of Biotechnology

This edition of the Carnival of Biotechnology features some interesting commentary on issues ethics, how to dress for drug ads, progress in biogenerics guidance, and innovation.


Signals Magazine presents a Financial Snapshot For September 2006


The Pharma Marketing Blog gives us some fashion advice in Lipitor’s Jarvik: Fop or Flop?


The Patent Baristas give us a double-header: Are Conflicts of Interest on The Rise? and Should Doctors Be Paid To Give Inside Info To Wall Street?


Signals Magazine presents an update on the Bio-Generic Regulatory Debate and matching commentary in Gearing Up For Bio-Generics


On Pharma asks Are Pharma’s Lean Projects Having an Impact?

Leave a Reply